Cargando…

Cnf1 Variants Endowed with the Ability to Cross the Blood–Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma

Among gliomas, primary tumors originating from glial cells, glioblastoma (GBM) identified as WHO grade IV glioma, is the most common and aggressive malignant brain tumor. We have previously shown that the Escherichia coli protein toxin cytotoxic necrotizing factor 1 (CNF1) is remarkably effective as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colarusso, Andrea, Maroccia, Zaira, Parrilli, Ermenegilda, Germinario, Elena Angela Pia, Fortuna, Andrea, Loizzo, Stefano, Ricceri, Laura, Tutino, Maria Luisa, Fiorentini, Carla, Fabbri, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290510/ https://www.ncbi.nlm.nih.gov/pubmed/32375387 http://dx.doi.org/10.3390/toxins12050291

Ejemplares similares

The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study
por: Fabbri, Alessia, et al.
Publicado: (2018)

Effects of the Rho GTPase‐activating toxin CNF1 on fibroblasts derived from Rett syndrome patients: A pilot study
por: Cittadini, Camilla, et al.
Publicado: (2023)

The Bacterial Toxin CNF1 Protects Human Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine-Induced Cell Damage: The Hypothesis of CNF1-Promoted Autophagy as an Antioxidant Strategy
por: Travaglione, Sara, et al.
Publicado: (2020)

The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases
por: Travaglione, Sara, et al.
Publicado: (2014)

Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?
por: Fiorentini, Carla, et al.
Publicado: (2020)

Improvement of Pseudoalteromonas haloplanktis TAC125 as a Cell Factory: IPTG-Inducible Plasmid Construction and Strain Engineering
por: Colarusso, Andrea, et al.
Publicado: (2020)

Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125
por: Colarusso, Andrea, et al.
Publicado: (2022)

CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice
por: Travaglione, Sara, et al.
Publicado: (2015)

Cell-to-Cell Propagation of the Bacterial Toxin CNF1 via Extracellular Vesicles: Potential Impact on the Therapeutic Use of the Toxin
por: Fabbri, Alessia, et al.
Publicado: (2015)

Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation
por: Urbinati, Chiara, et al.
Publicado: (2021)

New insights on Pseudoalteromonas haloplanktis TAC125 genome organization and benchmarks of genome assembly applications using next and third generation sequencing technologies
por: Qi, Weihong, et al.
Publicado: (2019)

CNF1 Improves Astrocytic Ability to Support Neuronal Growth and Differentiation In vitro
por: Malchiodi-Albedi, Fiorella, et al.
Publicado: (2012)

CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease
por: Loizzo, Stefano, et al.
Publicado: (2013)

Correction: CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease
por: Loizzo, Stefano, et al.
Publicado: (2013)

Development of high-copy number plasmids in Pseudoalteromonas haloplanktis TAC125
por: Calvanese, Marzia, et al.
Publicado: (2023)

Effects of the Escherichia coli Bacterial Toxin Cytotoxic Necrotizing Factor 1 on Different Human and Animal Cells: A Systematic Review
por: Carlini, Francesca, et al.
Publicado: (2021)

Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1): Toxin Biology, in Vivo Applications and Therapeutic Potential
por: Fabbri, Alessia, et al.
Publicado: (2010)

The Rho-activating CNF1 toxin from pathogenic E. coli: A risk factor for human cancer development?
por: Travaglione, Sara, et al.
Publicado: (2008)

Modelling hCDKL5 Heterologous Expression in Bacteria
por: Fondi, Marco, et al.
Publicado: (2021)

The bacterial protein CNF1 as a new strategy against Plasmodium falciparum cytoadherence
por: Messina, Valeria, et al.
Publicado: (2019)

The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells
por: Gall-Mas, Laura, et al.
Publicado: (2018)

Influence of production process design on inclusion bodies protein: the case of an Antarctic flavohemoglobin
por: Parrilli, Ermenegilda, et al.
Publicado: (2010)

Getting value from the waste: recombinant production of a sweet protein by Lactococcus lactis grown on cheese whey
por: Boumaiza, Mohamed, et al.
Publicado: (2018)

Development of an improved Pseudoalteromonas haloplanktis TAC125 strain for recombinant protein secretion at low temperature
por: Parrilli, Ermenegilda, et al.
Publicado: (2008)

A novel genetic system for recombinant protein secretion in the Antarctic Pseudoalteromonas haloplanktis TAC125
por: Cusano, Angela Maria, et al.
Publicado: (2006)

Acetate: friend or foe? Efficient production of a sweet protein in Escherichia coli BL21 using acetate as a carbon source
por: Leone, Serena, et al.
Publicado: (2015)

Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment
por: Pizzo, Federica, et al.
Publicado: (2022)

Membrane and Extracellular Matrix Glycopolymers of Colwellia psychrerythraea 34H: Structural Changes at Different Growth Temperatures
por: Casillo, Angela, et al.
Publicado: (2022)

Structural Investigation of the Oligosaccharide Portion Isolated from the Lipooligosaccharide of the Permafrost Psychrophile Psychrobacter arcticus 273-4
por: Casillo, Angela, et al.
Publicado: (2015)

The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model
por: Vannini, Eleonora, et al.
Publicado: (2014)

CATASAN Is a New Anti-Biofilm Agent Produced by the Marine Antarctic Bacterium Psychrobacter sp. TAE2020
por: D’Angelo, Caterina, et al.
Publicado: (2022)

The Cytotoxic Necrotizing Factor 1 from E. Coli: A Janus Toxin Playing with Cancer Regulators
por: Fabbri, Alessia, et al.
Publicado: (2013)

The bacterial toxin CNF1 as a tool to induce retinal degeneration reminiscent of retinitis pigmentosa
por: Guadagni, Viviana, et al.
Publicado: (2016)

Corrigendum: The bacterial toxin CNF1 as a tool to induce retinal degeneration reminiscent of retinitis pigmentosa
por: Guadagni, Viviana, et al.
Publicado: (2016)

Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens
por: Artini, Marco, et al.
Publicado: (2023)

Electro-cumulation CNF project
por: Grishin, V G
Publicado: (2000)

Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages
por: Vannini, Eleonora, et al.
Publicado: (2017)

Novel Tetrazole Derivatives Targeting Tubulin Endowed with Antiproliferative Activity against Glioblastoma Cells
por: Gallego-Yerga, Laura, et al.
Publicado: (2023)

Anti-Biofilm Activities from Marine Cold Adapted Bacteria Against Staphylococci and Pseudomonas aeruginosa
por: Papa, Rosanna, et al.
Publicado: (2015)

Association of Polygenic Risk Score and Bacterial Toxins at Screening Colonoscopy with Colorectal Cancer Progression: A Multicenter Case-Control Study
por: Piciocchi, Alfonso, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6cb64ole5mpvihdlh2bp9saons